SCHEMBL4892512

SCHEMBL4892512

N#Cc1ccc(C(=O)Nc2ccc(Nc3nccc(-c4ccncc4)n3)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 3/20 0.67
BCR P11274 3/20 0.67
PRKCA P17252 2/20 0.67
PDGFRB P09619 2/20 0.67
PDGFRA P16234 1/20 0.67
CAMK2D Q13557 3/20 0.58
IKBKB O14920 2/20 0.57
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
SRC P12931 1/20 0.54
PRKCD Q05655 1/20 0.54
NAMPT P43490 1/20 0.53
JAK2 O60674 5/20 0.52
MAPT P10636 2/20 0.52
GSK3A P49840 2/20 0.52
GSK3B P49841 2/20 0.52
HDAC1 Q13547 1/20 0.52
CYP11B1 P15538 1/20 0.51
CYP11B2 P19099 1/20 0.51
MAPK8 P45983 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4896152 0.90 ABL1 (0.84) ABL1BCRPRKCAPDGFRBPDGFRA
SCHEMBL4901694 0.89 ABL1 (0.83) ABL1BCRPRKCAPDGFRBPDGFRA
SCHEMBL4903357 0.86 PDGFRA (0.66) ABL1BCRPRKCAPDGFRBPDGFRA
SCHEMBL4897327 0.85 CAMK2D (0.61) ABL1BCRPRKCAPDGFRBPDGFRA
SCHEMBL4905540 0.85 ABL1 (0.62) ABL1BCRPRKCAPDGFRBPDGFRA
SCHEMBL4903404 0.85 JAK2 (0.68) ABL1BCRPRKCAPDGFRBPDGFRA
SCHEMBL13911480 0.83 CAMK2D (0.68) ABL1BCRPRKCAPDGFRBPDGFRA
SCHEMBL4905591 0.83 PDGFRA (0.64) ABL1BCRPRKCAPDGFRBPDGFRA
SCHEMBL14021027 0.82 CAMK2D (0.67) ABL1BCRPRKCAPDGFRBPDGFRA
SCHEMBL4375564 0.82 JAK2 (0.74) IKBKBMEN1KMT2AJAK2HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080187575-A1 Pyrimidine Derivatives VICHEM CHEMIE KFT (HU) 2008-08-07 US claimed
EP-1786781-A2 PYRIMIDINE DERIVATIVES GPC Biotech AG (DE) 2007-05-23 EP claimed
WO-2006021458-A2 PYRIMIDINE DERIVATIVES GPC BIOTECH AG (DE) 2006-03-02 WO claimed
US-20080187575-A1 Pyrimidine Derivatives VICHEM CHEMIE KFT (HU) 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080187575-A1 Pyrimidine Derivatives TYMP, TDP1, PNP ABL1 2843/4885BCR 2315/4885PRKCA 2607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.